Depression in Parkinson's disease [PDF]
, 2014 The prevalence of major and minor depression in Parkinson’s disease is around 30–40% but, unfortunately, depression remains frequently underrecognized and often undertreated.
Döme, Péter +2 more
core
Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data
Neuropsychopharmacology Reports, Volume 44, Issue 1, Page 234-239, March 2024.A meta‐analysis of large short‐term studies found no significant difference between asenapine doses of 10 and 20 mg/day for acute schizophrenia treatment. However, these studies' homogeneous patient populations may not accurately represent the diversity seen in clinical practice.
Yoshiteru Takekita +11 more
wiley +1 more source
Cyclopentenyl ethylamines active on CNS [PDF]
, 1992 Two new cyclopentenylethylamines were prepared and were submitted to a pharmacological screening together with some others previously described and now reprepared. All compounds exhibited different degrees of depressive activity on CNS and good analgesic
Dimich, P.M. +6 more
core
Prescribing cascades in ambulatory care: A structured synthesis of evidence
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 44, Issue 1, Page 87-96, January 2024.Abstract The strength of evidence for specific ambulatory care prescribing cascades, in which a marker drug is used to treat an adverse event caused by an index drug, has not been well characterized. To perform a structured, systematic, and transparent review of the evidence supporting ambulatory care prescribing cascades.
Faiza Shahid +5 more
wiley +1 more source
Virtual Affinity Fingerprints for Target Fishing: A New Application of Drug Profile Matching [PDF]
, 2013 We recently introduced Drug Profile Matching (DPM), a novel virtual affinity fingerprinting bioactivity prediction method. DPM is based on the docking profiles of ca.
Czobor, P. +6 more
core +1 more source
The effect of cabergoline on level of liver enzymes [PDF]
, 2011 زمینه و هدف: به علت اهمیت نقش کبد در ارتباط با متابولیسم داروهای شیمیایی و سنتز پروتئین های پلاسما و استفاده زیاد از داروی کابرگولین در درمان بیماری هیپرپرولاکتینمیا، پارکینسون و برخی اختلالات دیگر این مطالعه با هدف بررسی اثر داروی کابرگولین بر غلظت ...
Azarnoush, Jaleh. +2 more
core
Trends in inpatient antiparkinson drug use in the USA, 2001-2012 [PDF]
, 2015 Purpose: Although therapeutic options and clinical guidelines for Parkinson's disease (PD) have changed significantly in the past 15 years, prescribing trends in the USA remain unknown.
Bjerre, Lise M. +9 more
core +2 more sources
Establishment of framework for classification/categorisation and labelling of medicinal drugs and driving [PDF]
, 2011 The establishment of criteria for a European categorisation will have to serve most of the needs of all parties involved: health professionals, drug regulatory agencies, drug manufacturers and patients. Clear warnings and symbols are needed so patients
Fierro Lorenzo, María Inmaculada +2 more
core +1 more source
Managing Medicaid Pharmacy Benefits: Current Issues and Options [PDF]
, 2011 Examines issues and considerations for state reforms of Medicaid prescription drug reimbursement, pharmacy management, and cost sharing and other best practices for realizing ...
Robin Rudowitz +2 more
core
Dopamine Activation Preserves Visual Motion Perception Despite Noise Interference of Human V5/MT [PDF]
, 2016 Copyright © 2016 Yousif et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any ...
Abou-El-Ela Bourquin, Bilal +5 more
core +3 more sources